MeiraGTx Holdings plc

MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001735438

Price chart

Open-market purchases and sales by MGTX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 18, 20269:03 PM ETAug 18, 2026Forbes AlexandriaPRESIDENT & CEOSSaleOrdinary Shares−62K$13.86−$859.32K1.33M−4.5%SEC10b5-1
Jul 21, 20269:12 PM ETJul 21, 2026Giroux RichardCFO & COOSSaleOrdinary Shares−56K$12.51−$700.56K908.53K−5.8%SEC10b5-1
Jul 7, 20269:05 PM ETJul 7, 2026Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGYSSaleOrdinary Shares−27.66K$14.8042−$409.47K640.85K−4.1%SEC10b5-1
May 19, 2026May 19, 2026Forbes AlexandriaPRESIDENT & CEOSSaleOrdinary Shares−62K$9.17−$568.54K1.39M−4.3%SEC10b5-1
Apr 21, 2026Apr 21, 2026Giroux RichardCFO & COOSSaleOrdinary Shares−56K$10.22−$572.32K971.53K−5.4%SEC10b5-1

The largest institutional positions in MGTX at the end of Q2 2026.

Institutions holding MGTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Sanofi12,197,737$164.79M30.86%00.0%Unchanged
PERCEPTIVE ADVISORS LLC10,786,658$145.73M2.26%+460,555+4.5%Added
Rubric Capital Management LP9,100,000$122.94M1.13%+2,100,000+30.0%Added
JOHNSON & JOHNSON6,641,064$89.72M11.23%00.0%Unchanged
BlackRock, Inc.4,757,178$64.27M0.00%+1,589,030+50.2%Added